CHRONIC SPONTANEOUS URTICARIA
Clinical trials for CHRONIC SPONTANEOUS URTICARIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC SPONTANEOUS URTICARIA trials appear
Sign up with your email to follow new studies for CHRONIC SPONTANEOUS URTICARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill for stubborn hives passes blood pressure safety check
Disease control CompletedThis study tested a daily pill called remibrutinib in 144 adults with chronic spontaneous urticaria (long-term hives) that antihistamines couldn't control. The main goal was to check if the drug affects blood pressure over 12 weeks, while also seeing if it helps reduce hives. Par…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
New hope for chronic hives sufferers: drug trial shows promise
Symptom relief CompletedThis study tested an experimental drug called povorcitinib in 136 adults with chronic spontaneous urticaria (long-term hives) that standard antihistamines couldn't control. Participants received either the drug or a placebo for 12 weeks. The main goal was to see if the drug reduc…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Symptom relief
Last updated May 17, 2026 02:08 UTC
-
New hope for teens with stubborn hives: drug shows promise in trial
Symptom relief CompletedThis study tested a drug called ligelizumab in 49 teenagers (ages 12 to 18) with chronic spontaneous urticaria, a condition causing long-term hives and itching. The goal was to see if adding ligelizumab to standard antihistamines could better control symptoms. Results focused on …
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated May 17, 2026 02:05 UTC
-
New hope for teens with stubborn hives: xolair study shows promise
Symptom relief CompletedThis study looked at whether Xolair (omalizumab) is safe and effective for Chinese teenagers with chronic spontaneous urticaria (long-lasting hives and itching) that don't get better with standard antihistamines. Fifty-five teens took part, receiving Xolair for 12 weeks and then …
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
New shot could stop stubborn hives and itching
Symptom relief CompletedThis study tested a new medicine called LP-003 for people with chronic hives that still cause itching and welts even after taking allergy pills. 202 adults received the drug or a placebo as a shot under the skin. The main goal was to see if the drug could completely stop hives an…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
New hope for kids with stubborn hives: dupilumab studied
Symptom relief CompletedThis study tested the safety and drug levels of dupilumab in 15 children aged 2 to 12 with chronic spontaneous urticaria (CSU), also known as long-lasting hives, that did not get better with standard antihistamines. The children received dupilumab for 24 weeks and were monitored …
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated May 13, 2026 16:03 UTC
-
New hives drug tested in healthy volunteers for first time
Knowledge-focused CompletedThis early-stage study tested a new drug called LP-003 in 60 healthy adults to see if it is safe and how the body processes it. The study had two parts: one where people got a single dose, and another where they got multiple doses. The goal was to gather basic safety and drug-lev…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE1 • Sponsor: Longbio Pharma • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC